Pages that link to "Q41938664"
Jump to navigation
Jump to search
The following pages link to Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys (Q41938664):
Displaying 25 items.
- Exposure of chlorpromazine to 266 nm laser beam generates new species with antibacterial properties: contributions to development of a new process for drug discovery (Q28485991) (← links)
- Effective treatment with a tetrandrine/chloroquine combination for chloroquine-resistant falciparum malaria in Aotus monkeys (Q28709204) (← links)
- Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis (Q31571046) (← links)
- An overview of chemotherapeutic targets for antimalarial drug discovery (Q33586646) (← links)
- Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT. (Q33636449) (← links)
- Bisquinoline antimalarials: their role in malaria chemotherapy (Q33638392) (← links)
- Quinoline antimalarials: mechanisms of action and resistance. (Q34420587) (← links)
- Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries (Q34459699) (← links)
- A class of tricyclic compounds blocking malaria parasite oocyst development and transmission (Q34467923) (← links)
- In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine (Q35065754) (← links)
- Chemotherapy of drug-resistant malaria (Q35891386) (← links)
- Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets (Q36093316) (← links)
- Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro (Q36172400) (← links)
- Antimalarial drug therapy: the role of parasite biology and drug resistance (Q36652599) (← links)
- Ketotifen is an antimalarial prodrug of norketotifen with blood schizonticidal and liver-stage efficacy. (Q38465613) (← links)
- Potent enhancement of the sensitivity of Plasmodium falciparum to chloroquine by the bisbenzylisoquinoline alkaloid cepharanthin. (Q39051719) (← links)
- Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum (Q39241717) (← links)
- Drug resistance in malaria parasites of animals and man. (Q39351674) (← links)
- In vitro increase in chloroquine accumulation induced by dihydroethano- and ethenoanthracene derivatives in Plasmodium falciparum-parasitized erythrocytes (Q39652260) (← links)
- Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children (Q40658852) (← links)
- Cellular uptake of a catechol iron chelator and chloroquine into Plasmodium falciparum infected erythrocytes (Q41916023) (← links)
- Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin. (Q41917778) (← links)
- Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials (Q41924367) (← links)
- Reversal of Chloroquine Resistance of Plasmodium vivax in Aotus Monkeys (Q56339945) (← links)
- (Q58477048) (redirect page) (← links)